<DOC>
	<DOC>NCT01963793</DOC>
	<brief_summary>Topical Aprepitant in Prurigo Patients - An Exploratory Phase IIa Trial With Topically Applied Aprepitant in Patients With Prurigo</brief_summary>
	<brief_title>Topical Aprepitant in Prurigo Patients</brief_title>
	<detailed_description />
	<mesh_term>Pruritus</mesh_term>
	<mesh_term>Prurigo</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<criteria>Patient with Prurigo suffering from chronic pruritus Disease duration &gt; six month Therapy refractory to at least two previous antipruritic treatments with topical, intralesional or systemic corticosteroids, or other immunosuppressants, antihistamines, antipsychotics, antidepressants, anticonvulsants and/or UVirradiation Adult male or female patients, aged 18 to 80 years Concomitant medications that are primarily metabolized through Cytochrome P450 3A4 Applied topical antihistamines, corticosteroids or mast cell stabilizers to the skin less than 3 weeks prior to Visit 1 (Screening) or during the course of the trial UVirradiation during the last 6 weeks prior to Visit 1 (Screening) Prescribed systemic medications are limited Clinically significant abnormalities in Blood analyses Anamnestic excessive use of alcohol or tobacco or drugs Presence of active tumor disease or history of malignancies within five years prior to Visit 1 (Screening) Known or suspected hypersensitivity to component(s) of investigational products Within the last 30 days or current participation in any other interventional clinical trial Subjects who have received treatment with any nonmarketed drug substance (i.e., an agent which has not yet been made available for clinical use following registration) within the last 6 month Previously enrolled/randomised in this clinical trial In the opinion of the investigator, the subject is unlikely to comply with the Clinical Study Protocol (e.g., alcoholism, drug dependency or psychotic state) Females who are pregnant, of childbearing potential and wishing to become pregnant during the trial or are breast feeding Females of childbearing potential with positive pregnancy test Subjects (or their partner) not using an adequate method of contraception (according to national requirements, as applicable)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Pruritus</keyword>
</DOC>